logo
Hepatocellular carcinoma
Introduction of NS5A mutations enables subgenomic HCV replicon derived from chimpanzee-infectious HC-J4 isolate to replicate efficiently in Huh-7 cells
Interferon-γ-associated responses to woodchuck hepatitis virus infection in neonatal woodchucks and virus-infected hepatocytes
Racial differences in responses to interferon-β-1a in chronic hepatitis C unresponsive to interferon-α
The use of lamivudine for patients with acute hepatitis B (a series of cases)
Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis B
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance
Kinetics of hepatitis B viral load during 48 weeks of treatment with 600 mg vs 100 mg of lamivudine daily*
Effects of ribavirin combined with interferon-α2b on viral kinetics during first 12 weeks of treatment in patients with hepatitis C virus genotype 1 and high baseline viral loads
Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections
Antinuclear antibodies (ANA) in chronic hepatitis C virus infection
HCV infection and oral lichen planus
Hepatitis C virus infection in Egyptian children
Immune thrombocytopenic purpura in a patient treated with interferon alfacon-1